Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBS for neuroprotective drug evaluation in ischemic stroke
NCT01388738Phase 3Completed
- Start
- Jan 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cerebrolysin, citicoline, choline alfoscerate in ischemic stroke. Started Jan 2011; status: completed.
02
Drugs
cerebrolysinciticolinecholine alfoscerate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01388738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388738.